Literature DB >> 12890953

Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation.

Onder Yaman1, Cağatay Göğüş, Ozden Tulunay, Zafer Tokatli, Eriz Ozden.   

Abstract

OBJECTIVES: Subclinical prostatitis is a very frequent histologic finding in pathological examinations of prostate biopsy and prostate surgery material. In this study, we tried to investigate the correlation between the morphological parameters of histological prostatitis and total serum prostate-specific antigen (PSA)-PSA density (PSAD) to determine if either the extent or aggressiveness of inflammation might affect serum PSA.
METHODS: 269 patients who had undergone TURP or transvesical prostatectomy with pathological diagnosis of BPH and prostatitis were included in the study. We retrospectively reviewed and scored the extent and aggressiveness of inflammation in prostate specimens of BPH, according to the scale that has been reported by Irani et al. and then correlated those scores with PSA and PSAD.
RESULTS: When the inflammation grades correlated with PSA and PSAD, the extent of the inflammation did not show a significant correlation with total PSA and PSAD (p > 0.05). However, there was a statistically significant correlation between aggressiveness grades and total PSA and PSAD (p < 0.001). Median PSA levels in grades 0, 1 and 2 of aggressiveness of inflammation were 3.2, 4.2 and 5.8 respectively.
CONCLUSION: Aggressiveness grade of the inflammation in subclinical prostatitis is the most important morphological factor that is responsible for PSA elevation. We believe that it should be a more accurate guide for the clinician if pathologists report on the aggressiveness grades of the inflammation, especially on initial prostate biopsies, in order to help for timing of the further biopsy. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890953     DOI: 10.1159/000071839

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  12 in total

1.  The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis.

Authors:  Cuneyt Ozden; Ozdem Levent Ozdal; Ozer Guzel; Ozge Han; Selda Seckin; Ali Memis
Journal:  Int Urol Nephrol       Date:  2006-11-17       Impact factor: 2.370

2.  Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Authors:  M H Umbehr; B Gurel; T J Murtola; S Sutcliffe; S B Peskoe; C M Tangen; P J Goodman; I M Thompson; S M Lippman; M S Lucia; H L Parnes; C G Drake; W G Nelson; A M De Marzo; E A Platz
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-05-05       Impact factor: 5.554

3.  Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.

Authors:  D M Moreira; J C Nickel; G L Andriole; R Castro-Santamaria; S J Freedland
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-19       Impact factor: 5.554

4.  The correlation of extent and grade of inflammation with serum PSA levels in patients with IV prostatitis.

Authors:  Li Gui-Zhong; Man Libo; Huang Guanglin; Wang Jianwei
Journal:  Int Urol Nephrol       Date:  2010-09-05       Impact factor: 2.370

5.  Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection.

Authors:  Tomonori Kato; Akira Komiya; Akihiro Morii; Hiroaki Iida; Takatoshi Ito; Hideki Fuse
Journal:  Oncol Lett       Date:  2016-06-09       Impact factor: 2.967

6.  Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Bora Gurel; M Scott Lucia; Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; Alan R Kristal; Howard L Parnes; Ashraful Hoque; Scott M Lippman; Siobhan Sutcliffe; Sarah B Peskoe; Charles G Drake; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-18       Impact factor: 4.254

7.  The effect of antibiotherapy on prostate-specific antigen levels and prostate biopsy results in patients with levels 2.5 to 10 ng/mL.

Authors:  Gokhan Toktas; Murat Demiray; Erkan Erkan; Ramazan Kocaaslan; Ugur Yucetas; Suleyman Erdinc Unluer
Journal:  J Endourol       Date:  2013-08       Impact factor: 2.942

8.  Antibacterial therapy improves the effectiveness of prostate cancer detection using prostate-specific antigen in patients with asymptomatic prostatitis.

Authors:  Ping Tang; Ke-Ji Xie; Bin Wang; Xiang-Rong Deng; Ru-Biao Ou
Journal:  Int Urol Nephrol       Date:  2009-06-23       Impact factor: 2.370

Review 9.  Prostatitis and serum prostate-specific antigen.

Authors:  Puneet Sindhwani; Christopher M Wilson
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

10.  Incidence of histological prostatitis and its correlation with PSA density.

Authors:  Affonso Celso Piovesan; Geraldo de Campos Freire; Fabio César Miranda Torricelli; Paulo Cordeiro; Renato Yamada; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.